Correlation Between Annovis Bio and Cognition Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annovis Bio and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annovis Bio and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annovis Bio and Cognition Therapeutics, you can compare the effects of market volatilities on Annovis Bio and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annovis Bio with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annovis Bio and Cognition Therapeutics.

Diversification Opportunities for Annovis Bio and Cognition Therapeutics

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Annovis and Cognition is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Annovis Bio and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Annovis Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annovis Bio are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Annovis Bio i.e., Annovis Bio and Cognition Therapeutics go up and down completely randomly.

Pair Corralation between Annovis Bio and Cognition Therapeutics

Given the investment horizon of 90 days Annovis Bio is expected to under-perform the Cognition Therapeutics. In addition to that, Annovis Bio is 1.76 times more volatile than Cognition Therapeutics. It trades about -0.28 of its total potential returns per unit of risk. Cognition Therapeutics is currently generating about -0.21 per unit of volatility. If you would invest  79.00  in Cognition Therapeutics on November 9, 2024 and sell it today you would lose (15.00) from holding Cognition Therapeutics or give up 18.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Annovis Bio  vs.  Cognition Therapeutics

 Performance 
       Timeline  
Annovis Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Cognition Therapeutics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cognition Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cognition Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Annovis Bio and Cognition Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annovis Bio and Cognition Therapeutics

The main advantage of trading using opposite Annovis Bio and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annovis Bio position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.
The idea behind Annovis Bio and Cognition Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Correlations
Find global opportunities by holding instruments from different markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance